4-122923222-G-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_145207.3(AFG2A):āc.80G>Cā(p.Cys27Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00849 in 1,614,156 control chromosomes in the GnomAD database, including 906 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_145207.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPATA5 | ENST00000274008.5 | c.80G>C | p.Cys27Ser | missense_variant | 1/16 | 1 | NM_145207.3 | ENSP00000274008.3 | ||
SPATA5 | ENST00000422835.2 | n.122G>C | non_coding_transcript_exon_variant | 1/15 | 1 | |||||
SPATA5 | ENST00000675612.1 | c.80G>C | p.Cys27Ser | missense_variant | 1/17 | ENSP00000502453.1 | ||||
SPATA5 | ENST00000674886.1 | n.145G>C | non_coding_transcript_exon_variant | 1/11 |
Frequencies
GnomAD3 genomes AF: 0.0429 AC: 6526AN: 152162Hom.: 461 Cov.: 32
GnomAD3 exomes AF: 0.0119 AC: 2998AN: 251454Hom.: 200 AF XY: 0.00850 AC XY: 1155AN XY: 135906
GnomAD4 exome AF: 0.00491 AC: 7174AN: 1461874Hom.: 448 Cov.: 31 AF XY: 0.00421 AC XY: 3063AN XY: 727236
GnomAD4 genome AF: 0.0429 AC: 6535AN: 152282Hom.: 458 Cov.: 32 AF XY: 0.0410 AC XY: 3051AN XY: 74478
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Aug 30, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 21, 2018 | - - |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 01, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at